Loss of high‐affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment
Authors:
- 10 July 2007
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 21 (14) , 4028-4037
Abstract
Pharmacological activation of nicotinic acetylcholine receptors (nAChRs) exerts neuroprotective effects in cultured neurons and the intact animal. Much less is known about a physiological protective role of nAChRs. To understand whether endogenous activation of β2* nAChRs contributes to the maintenance of the functional and morphological integrity of neural tissue, adult β2‐/‐ mice were subjected to in vivo challenges that cause neurodegeneration and cognitive impairment (intrahippocampal injection of the excitotoxin quinolinic acid), or neuroprotection and cognitive potentiation (2‐month exposure to an enriched environment). The excitotoxic insult caused an increased deficit in the Morris water maze learning curve and increased loss of hippocampal pyramidal cells in β2 ‐/‐ mice. Exposure to an enriched environment improved performance in contextual and cued fear conditioning and object recognition tests in β2+/+, whereas the improvement was absent in β2‐/‐ mice. In addition, β2+/+, but not β2‐/‐, mice exposed to an enriched environment showed a significant hypertrophy of the CA1/3 regions. Thus, lack of β2* nAChRs increased susceptibility to an excitotoxic insult and diminished the positive effects of an enriched environment. These results may be relevant to understanding the pathophysiological consequences of the marked decrease in nAChRs that occurs in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.— Zanardi, A., Ferrari, R., Leo, G., Maskos, U., Changeux, J.‐P., Zoli, M. Loss of high affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment. FASEB J . 21, 4028–4037 (2007)Keywords
This publication has 53 references indexed in Scilit:
- Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitationNeurobiology of Disease, 2006
- Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease TherapyThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Attenuation of Aβ deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smokingNeuropathology and Applied Neurobiology, 2005
- Environmental Enrichment Mitigates Cognitive Deficits in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2005
- Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic MiceCell, 2005
- Reduced levels of Aβ 40 and Aβ 42 in brains of smoking controls and Alzheimer's patientsNeurobiology of Disease, 2004
- Histological and Behavioral Protection by (−)-Nicotine against Quinolinic Acid-Induced Neurodegeneration in the HippocampusNeurobiology of Learning and Memory, 1998
- GTS-21, a Nicotinic Agonist, Attenuates Multiple Infarctions and Cognitive Deficit Caused by Permanent Occlusion of Bilateral Common Carotid Arteries in RatsThe Japanese Journal of Pharmacology, 1998
- Nicotinic receptor stimulation protects neurons against β‐amyloid toxicityAnnals of Neurology, 1997
- Risk Factors for Dementia in Parkinson's Disease: Effect of EducationNeuroepidemiology, 1995